SIC
COGT icon

SJS Investment Consulting’s Cogent Biosciences COGT Stock Holding History

SJS Investment Consulting’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$697 Buy
18
+12
+200% +$420 ﹤0.01% 2147
2026
Q1 		$231 Buy
+6
New +$222 ﹤0.01% 1953

Other funds holding COGT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

SJS Investment Consulting's COGT Position: Q2 2026 in Review

SJS Investment Consulting increased its Cogent Biosciences (COGT) stake by 200% in Q2 2026, buying an estimated $420 and bringing the position to 18 shares worth $697. The position accounts for ﹤0.01% of the portfolio, ranked #2147.

SJS Investment Consulting first reported a position in COGT in Q1 2026 and has held it in 2 quarters since. 40 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • SJS Investment Consulting held 18 shares of Cogent Biosciences worth $697 as of Q2 2026.
  • SJS Investment Consulting bought 12 Cogent Biosciences shares in Q2 2026, an estimated $420.
  • Cogent Biosciences made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2147 holding.
  • SJS Investment Consulting first reported a position in Cogent Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 40 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.